| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
Departments of 1 Surgery and 2 Cancer Biology, Vanderbilt-Ingram Cancer Center; and Departments of 3 Medicine and 4 Medical Pathology, Vanderbilt University School of Medicine, Nashville, Tennessee
Requests for reprints: Pran K. Datta, Surgical Oncology Division, Department of Surgery, Vanderbilt University School of Medicine, 1161 21st Avenue South, A-3310C MCN, Nashville, TN 37232. Phone: 615-343-1280; Fax: 615-343-1355; E-mail: pran.datta{at}vanderbilt.edu.
The development and progression of malignancies is a complex multistage process that involves the contribution of a number of genes giving growth advantage to cells when transformed. The role of transforming growth factor-ß (TGF-ß) in carcinogenesis is complex with tumor-suppressor or prooncogenic activities depending on the cell type and the stage of the disease. We have previously reported the identification of a novel WD-domain protein, STRAP, that associates with both TGF-ß receptors and that synergizes with the inhibitory Smad, Smad7, in the negative regulation of TGF-ßinduced transcription. Here, we show that STRAP is ubiquitously expressed and is localized in both cytoplasm and nucleus. STRAP is up-regulated in 60% colon and in 78% lung carcinomas. Stable expression of STRAP results in activation of mitogen-activated protein kinase/extracellular signal-regulated kinase pathway and in down-regulation of the cyclin-dependent kinase inhibitor p21Cip1, which results in retinoblastoma protein hyperphosphorylation. In addition, we have observed that Smad2/3 phosphorylation, TGF-ßmediated transcription, and growth inhibition are induced in STRAP-knockout mouse embryonic fibroblasts compared with wild-type cells. Ectopic expression of STRAP in A549 lung adenocarcinoma cell line inhibits TGF-ßinduced growth inhibition and enhances anchorage-independent growth of these cells. Moreover, overexpression of STRAP increases tumorigenicity in athymic nude mice. Knockdown of endogenous STRAP by small interfering RNA increases TGF-ß signaling, reduces ERK activity, increases p21Cip1 expression, and decreases tumorigenicity. Taken together, these results suggest that up-regulation of STRAP in human cancers may provide growth advantage to tumor cells via TGF-ßdependent and TGF-ßindependent mechanisms, thus demonstrating the oncogenic function of STRAP. (Cancer Res 2006; 66(12): 6156-66)
This article has been cited by other articles:
![]() |
H. Jung, H.-A. Seong, and H. Ha NM23-H1 Tumor Suppressor and Its Interacting Partner STRAP Activate p53 Function J. Biol. Chem., November 30, 2007; 282(48): 35293 - 35307. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cao, K. Yu, C. Banh, V. Nguyen, A. Ritz, B. J. Raphael, Y. Kawakami, T. Kawakami, and A. R. Salomon Quantitative Time-Resolved Phosphoproteomic Analysis of Mast Cell Signaling J. Immunol., November 1, 2007; 179(9): 5864 - 5876. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chiosea, E. Jelezcova, U. Chandran, J. Luo, G. Mantha, R. W. Sobol, and S. Dacic Overexpression of Dicer in Precursor Lesions of Lung Adenocarcinoma Cancer Res., March 1, 2007; 67(5): 2345 - 2350. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Anumanthan, S. K. Halder, D. B. Friedman, and P. K. Datta Oncogenic Serine-Threonine Kinase Receptor-Associated Protein Modulates the Function of Ewing Sarcoma Protein through a Novel Mechanism. Cancer Res., November 15, 2006; 66(22): 10824 - 10832. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |